Asthmanefrin Racepinephrine Bronchodilator (racephedrine recalls
The FDA has published 1 recall involving Asthmanefrin Racepinephrine Bronchodilator (racephedrine since 2023. The latest was reported on 1 Feb 2023. Most were for packaging defects. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2023
Last 12 months0reported
Class I00% of total
Ongoing0latest 1 Feb 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why asthmanefrin racepinephrine bronchodilator (racephedrine is recalled
Companies
By year
All asthmanefrin racepinephrine bronchodilator (racephedrine recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Asthmanefrin Racepinephrine Inhalation Solution recalled by Nephron Sc | Nephron Sc | Packaging Defects | Nationwide |
Should you stop taking Asthmanefrin Racepinephrine Bronchodilator (racephedrine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.